Ahs Cancer Control Alberta
Clinical trials sponsored by Ahs Cancer Control Alberta, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Home chemo shot study could free myeloma patients from hospital trips Results expected Dec 2026 (estimated)
- Can allergy med stop bone pain in stem cell transplants? Results expected Dec 2026 (estimated)
- New combo therapy aims to ease swallowing in incurable esophageal cancer Results expected Apr 2027 (estimated)
-
Can methotrexate replace steroids for immunotherapy joint pain?
Disease control Stopped earlyThis study tested methotrexate, a common arthritis drug, for treating joint pain and swelling caused by cancer treatments that boost the immune system. The goal was to help patients stop taking steroids like prednisone, which have many side effects. The trial was stopped early af…
Phase 2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a sharper PET tracer light up hidden neuroendocrine tumors?
Diagnosis Stopped earlyThis trial tests an injected tracer called Gallium-68 HA-DOTATATE, which binds to somatostatin receptors found on most neuroendocrine tumors. Researchers want to see if a PET/CT or PET/MRI scan using this tracer is safe and accurately detects these tumors compared with standard C…
Phase 1/2 • Sponsor: AHS Cancer Control Alberta • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
Can an app help cancer patients feel better during chemo?
Symptom relief Stopped earlyThis study tested whether a web-based symptom tracking tool could improve quality of life for people with early-stage breast or colorectal cancer receiving chemotherapy. Participants were randomly assigned to either use the online tool to report symptoms between clinic visits or …
Sponsor: AHS Cancer Control Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC